Cargando…
Mitochondrial Pyruvate Carrier Inhibition Attenuates Hepatic Stellate Cell Activation and Liver Injury in a Mouse Model of Metabolic Dysfunction-associated Steatotic Liver Disease
Hepatic stellate cells (HSC) are non-parenchymal liver cells that produce extracellular matrix comprising fibrotic lesions in chronic liver diseases. Prior work demonstrated that mitochondrial pyruvate carrier (MPC) inhibitors suppress HSC activation and fibrosis in a mouse model of metabolic dysfun...
Autores principales: | Habibi, Mohammad, Ferguson, Daniel, Eichler, Sophie J., Chan, Mandy M., LaPoint, Andrew, Shew, Trevor M., He, Mai, Lutkewitte, Andrew J., Schilling, Joel D., Cho, Kevin Y., Patti, Gary J., Finck, Brian N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949033/ https://www.ncbi.nlm.nih.gov/pubmed/36824926 http://dx.doi.org/10.1101/2023.02.13.528384 |
Ejemplares similares
-
Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism
por: Ferguson, Daniel, et al.
Publicado: (2023) -
Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice
por: Yiew, Nicole K.H., et al.
Publicado: (2023) -
Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and glycerol-mediated gluconeogenesis in mice
por: Yiew, Nicole K.H., et al.
Publicado: (2023) -
The impact of cortisol in steatotic and non‐steatotic liver surgery
por: Cornide‐Petronio, María Eugenia, et al.
Publicado: (2017) -
Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1
por: Lutkewitte, Andrew J., et al.
Publicado: (2021)